NDC product
Curist Mucus Relief
NDC 72559-017 · Little Pharma, Inc.
Key facts
| Product NDC | 72559-017 |
|---|---|
| Proprietary name | Curist Mucus Relief |
| Nonproprietary name | Guaifenesin |
| Substances | GUAIFENESIN |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Labeler | Little Pharma, Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA213420 |
| Pharmacologic classes | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE] |
| Marketing start | Feb 21, 2022 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: